About Immunai:
Immunai is an engineering-first platform company aiming to improve therapeutic decision-making throughout the drug discovery and development process. We are mapping the immune system at unprecedented scale and granularity and applying machine learning to this massive clinico-immune database, in order to generate novel insights into disease pathology for our partners - pharma companies and research institutes. We provide a comprehensive, end-to-end solution - from data generation and curation to therapeutics development, that continuously supports and validates the capabilities of our platform.
As drug development is becoming increasingly inefficient, our ultimate goal is to help bring breakthrough medicines to patients as quickly and successfully as possible.
Immunai is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
About the role:
We are looking for an AI Engineer to play a central role in building, evaluating, and advancing Immunai’s AI models. You will own and evolve Immunai’s benchmarking and evaluation capabilities for foundation models and multimodal systems, while also working closely with modeling teams to support model development, iteration, and validation. This role sits at the intersection of software engineering, model understanding, and applied AI, with broad influence on how models are built, compared, and improved across the organization.
Location: Ramat Gan, Israel (hybrid model)
What will you do?
Required qualifications:
Desired personal traits:
When you apply for a role at Immunai, we process your personal data (such as CV, contact details, and professional background) to assess your suitability for current and future roles. Your information may be shared internally with relevant employees and stored or processed by trusted service providers, some of whom may be located outside your country of residence. You can read more about how we process data here: https://www.immunai.com/privacy-policy/

Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes